JAGX (Jaguar Health) Interest Expense: $-0.87 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JAGX Jaguar Health Inc JAGX
39 GF Score
Price $2.71
GF Value $181.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Jaguar Health Interest Expense?

Jaguar Health JAGX +3.04% 39 Interest Expense is $-0.87 Mil as of Jun. 2026. GuruFocus rates JAGX with a GF Score™ of 39/100 and a GF Value™ of $181.70 (Possible Value Trap). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jaguar Health's interest expense for the three months ended in Jun. 2026 was $ -0.16 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.87 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jaguar Health's Operating Income for the three months ended in Jun. 2026 was $ -7.60 Mil. Jaguar Health's Interest Expense for the three months ended in Jun. 2026 was $ 0.00 Mil. Jaguar Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jaguar Health  (NAS:JAGX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jaguar Health's Interest Expense for the three months ended in Jun. 2026 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2026 was $-7.60 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was $2.60 Mil.

Jaguar Health's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

GuruFocus does not calculate Jaguar Health's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Jaguar Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Jaguar Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jaguar Health Interest Expense Chart

Jaguar Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.42 -12.72 -6.38 -0.23 -0.07

Jaguar Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 -0.70 -0.16
JAGX
39GF Score
Jaguar Health Inc JAGX
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jaguar Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.87 Mil mean?
Jaguar Health (JAGX) has a Interest Expense of $-0.87 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Jaguar Health and its competitors.
Is Jaguar Health's Interest Expense too high?
Jaguar Health's current Interest Expense is $-0.87 Mil. Overall, Jaguar Health has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jaguar Health's Interest Expense compare to APVO and GRI?
Jaguar Health's Interest Expense of $-0.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Jaguar Health and its competitors. Jaguar Health's current Interest Expense is $-0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaguar Health stock overvalued right now?
Based on GuruFocus' analysis, Jaguar Health (JAGX) is currently considered Possible Value Trap. The stock's GF Value™ is $181.70, compared to a current price of $2.71 — trading 98.5% below its estimated fair value. The current Interest Expense is $-0.87 Mil. Jaguar Health's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Jaguar Health (JAGX), the current Interest Expense is $-0.87 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jaguar Health (JAGX) Overvalued in 2026?

Based on GuruFocus' analysis, Jaguar Health stock appears to be undervalued. The current stock price of $2.71 is trading 98.5% below its estimated GF Value™ of $181.70. GuruFocus considers Jaguar Health to be Possible Value Trap.

Key valuation signals for JAGX:

  • Interest Expense: $-0.87 Mil
  • GF Value™: $181.70 vs. price of $2.71 (98.5% below fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the JAGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jaguar Health Business Description

Address 200 Pine Street, Suite 400, San Francisco, CA, USA, 94104
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
39GF Score

Get the complete analysis for JAGX

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.71
Price
$181.70
GF Value